Louise Bach Callesen
6PUBLICATIONS
5CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Oct 31, 2023
Circulating DNA and frequency of colorectal cancer brain metastases in a presumed high-risk group.Louise Bach Callesen, Anders Kindberg Boysen, Rikke Fredslund Andersen
|Sep 22, 2023
ctDNA-guided adjuvant treatment after radical-intent treatment of metastatic spread from colorectal cancer-the first interim results from the OPTIMISE study.Louise Bach Callesen, Torben Frøstrup Hansen, Rikke Fredslund Andersen
|Mar 23, 2023
Time for a lead-time definition? Author response to 'Why the length of recurrence free survival or "lead-times" can be misleading. Comment on: Callesen LB, Takacova T, Hamfjord J, et al. Circulating DNA in patients undergoing loco-regional treatment of colorectal cancer metastases: a systematic review and meta-analysis'.Karen-Lise Garm Spindler, Louise Bach Callesen, Dirk Arnold
|Nov 07, 2022
Circulating DNA in patients undergoing loco-regional treatment of colorectal cancer metastases: a systematic review and meta-analysis.Louise B Callesen, Tana Takacova, Julian Hamfjord
|Sep 12, 2022
OPTIMISE: Optimisation of treatment selection and follow-up in oligometastatic colorectal cancer - a ctDNA-guided phase II randomised approach. Study protocol.Louise Bach Callesen, Torben Frøstrup Hansen, Rikke Fredslund Andersen
|Apr 20, 2022
Circulating tumour DNA and its clinical utility in predicting treatment response or survival in patients with metastatic colorectal cancer: a systematic review and meta-analysis.Louise B Callesen, Julian Hamfjord, Anders K Boysen
Pageof 1
